arBtrage CAPITALIZING MARKETS checking… Sign in

Dyadic International, Inc.

DYAI Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$0.71
▼ -1.8% Today
as of Jun 7, 07:13 ET
Last 30 days -12.35% Apr 28 → Jun 05
$0.68 $0.72 $0.75 $0.78 $0.82 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$0.70
High
$0.72
Low
$0.69
Volume
$79,647
Avg Vol
$173,370
Mkt Cap
$26M
P/E (TTM)
Beta
52w High
$1.35
52w Low
$0.65
Div Yield
Shares Out
$36M

Overview

52-week range
$0.65
$1.35
9% of range
Avg surprise (last 0)
Avg reaction (last 2)
-1.6%
0% positive
Latest IV / EM
4521%
EM ±626.2% · $3 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.57$-0.31$-0.04$0.22$0.49 Actual $-0.07Actual $-0.01Actual $-0.07Actual $-0.06Actual $-0.06Actual $-0.05 JunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-2M$-1M$5,076$1M$2M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 13, 2026Mar/2026 $-0.05 +28.6% -1.4% earnings
Tue Sep 30, 2025Sep 2025 $-0.06 financials
Mon Jun 30, 2025Jun 2025 $-0.06 financials
Wed May 14, 2025Mar/2025 $-0.07 -1.9% earnings
Mon Sep 30, 2024Sep 2024 $-0.01 financials
Sun Jun 30, 2024Jun 2024 $-0.07 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$1M$1M$966,630$393,572$2M$385,896
Cost of revenue$791,840$1M$297,658$395,894$301,956
Gross profit
Operating income$-2M$-2M$-2M$-2M$-202,614$-2M
Net income$-2M$-2M$-2M$-2M$-203,460$-2M
EPS (diluted)$-0.05$-0.06$-0.06$-0.07$-0.01$-0.07

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$4M$5M$6M$2M$5M$7M$6M$6M
Inventory
Total current assets$8M$10M$12M$7M$8M$10M$11M$11M
Total assets$8M$10M$12M$8M$8M$10M$11M$11M
Long-term debt
Total liabilities$8M$9M$9M$9M$7M$7M$7M$7M
Total equity$-407,732$1M$3M$-529,701$923,611$2M$3M$3M

Implied volatility — last 90 days

4516%4518%4521%4523%4526% Jun 07 — IV 4521% · EM ±626.2%

Sector peers